EC
HIMS icon

Elequin Capital’s Hims & Hers Health HIMS Stock Holding History

Elequin Capital’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.27M Buy
109,353
+109,107
+44,352% +$2.58M 0.19% 47
2025
Q4 		$7.99K Buy
+246
New +$10.5K ﹤0.01% 263

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Elequin Capital's HIMS Position: Q1 2026 in Review

Elequin Capital increased its Hims & Hers Health (HIMS) stake by 44,352% in Q1 2026, buying an estimated $2.58M and bringing the position to 109,353 shares worth $2.27M. The position accounts for 0.19% of the portfolio, ranked #47.

Elequin Capital first reported a position in HIMS in Q4 2025 and has held it in 2 quarters since. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Elequin Capital held 109,353 shares of Hims & Hers Health worth $2.27M as of Q1 2026.
  • Elequin Capital bought 109,107 Hims & Hers Health shares in Q1 2026, an estimated $2.58M.
  • Hims & Hers Health made up 0.19% of Elequin Capital's portfolio in Q1 2026, its #47 holding.
  • Elequin Capital first reported a position in Hims & Hers Health in Q4 2025 and has held it in 2 quarters since.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.